Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jagp.2024.04.004 | DOI Listing |
Acta Neuropsychiatr
October 2024
CarVasCare Research Group, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, Cuenca, Spain.
There is a high prevalence of neuropsychiatric disorders in myotonic dystrophy types 1 and 2 (DM1 and DM2), including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in DM1, and depression and anxiety in both DMs. The aim of this systematic review and meta-analysis was to estimate the prevalence of ASD, ADHD, depression and anxiety in the population with DM, and their association with disease onset. A systematic search of Medline, Scopus, Web of Science, and the Cochrane Library was conducted from inception to November 2023.
View Article and Find Full Text PDFAust N Z J Psychiatry
October 2024
Blackwattle Clinic, NSW, Pyrmont, Australia.
J Huntingtons Dis
July 2024
Department of Clinical Genetics, Sheffield Children's Hospital, Sheffield, UK.
Am J Geriatr Psychiatry
September 2024
Department of Gerontology (AR), University of Haifa, Haifa, Israel. Electronic address:
Aust N Z J Psychiatry
May 2024
Queensland Centre for Mental Health Research, Brisbane, QLD, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!